Authorisation and supervision of medicinal products for human use and governing rules for the European Medicines Agency
10 November 2026 | Lead committee adopted its 2nd-reading recommendation
What's next: Plenary decides on the Council's position within the 3-month (+1 on request) second-reading window: approve it or stay silent (the act is adopted), amend it, or reject it — amendment or rejection needs an absolute majority of all MEPs (361 of 720).
Posted 10 November 2026
Sign in to vote or follow